{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:05:17Z","timestamp":1762898717664},"reference-count":31,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2011,9,6]],"date-time":"2011-09-06T00:00:00Z","timestamp":1315267200000},"content-version":"vor","delay-in-days":4965,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American J Rep Immunol"],"published-print":{"date-parts":[[1998,2]]},"abstract":"<jats:p>PROBLEM: The questions of whether production of mixed lymphocyte reaction\u2010blocking factors (MLR\u2010BFs) after immunotherapy with lymphocytes for recurrent spontaneous abortion (RSA) has prognostic value and whether cytotoxic antibodies are also involved were tested.<\/jats:p><jats:p>METHOD OF STUDY: A prospective study with 33 patients who had a history of two or more abortions, lacking MLR\u2010BFs, was carried out. The patients received immunizations with lymphocytes and 6 weeks or later were tested for seroconversion of MLR\u2010BFs. Seventeen of these thirty\u2010three patients were evaluated for antipaternal cytotoxic antibodies. The results were correlated with the outcome of the next pregnancy after treatment. RESULTS: Eighty percent of the 33 patients had a live child. Of those patients having success, only 50% produced MLR\u2010BFs. Of those patients having a new loss, five did and two did not produce MLR\u2010BF (<jats:italic>P &gt;<\/jats:italic> 0.05). Regarding the 17 patients tested for cytotoxic antibodies, 4 of the 5 patients who tested positive had a new abortion, whereas only 1 of 12 whose tests remained negative did not have gestational success (<jats:italic>P<\/jats:italic> &lt; 0.01). CONCLUSION: The presence of MLR\u2010BFs is not a prognostic criterium for the outcome of pregnancy after alloimmunotherapy, and, consequently, it is not a good diagnostic tool for RSA of alloimmune cause.<\/jats:p>","DOI":"10.1111\/j.1600-0897.1998.tb00343.x","type":"journal-article","created":{"date-parts":[[2011,9,6]],"date-time":"2011-09-06T11:53:04Z","timestamp":1315309984000},"page":"120-124","source":"Crossref","is-referenced-by-count":9,"title":["The Production of MLR\u2010Blocking Factors After Lymphocyte Immunotherapy for RSA Does Not Predict the Outcome of Pregnancy"],"prefix":"10.1111","volume":"39","author":[{"given":"Ruth Beatriz","family":"Pe\u00f1a","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela P.","family":"Cadavid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge H.","family":"Botero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gloria P.","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda I.","family":"Gallego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge E.","family":"Ossa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,9,6]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(16)32690-4"},{"key":"e_1_2_1_3_2","doi-asserted-by":"crossref","first-page":"766771","DOI":"10.1016\/S0015-0282(16)49035-7","article-title":"Blood transfusions generate\/increase previously absent\/weak blocking antibody in women with habitual abortion","volume":"44","author":"Unander AM","year":"1985","journal-title":"Fertil Steril"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0897.1986.tb00001.x"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0897.1992.tb00815.x"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(83)91078-4"},{"key":"e_1_2_1_7_2","article-title":"Is antipaternal cytotoxic antibody a valid marker in the management of recurrent abortion","volume":"1280","author":"Regan L.","year":"1987","journal-title":"Lancet"},{"key":"e_1_2_1_8_2","doi-asserted-by":"crossref","unstructured":"SargentIL WilkinsT. RedmanCW:Maternal immune responses to the fetus in early pregnancy and recurrent miscarriage. Lancet1988;1099\u20131103.","DOI":"10.1016\/S0140-6736(88)90522-3"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(16)55313-8"},{"key":"e_1_2_1_10_2","first-page":"59","article-title":"Host responses to intrauterine tissue, cellular and fetal allografts","volume":"21","author":"Beer AE","year":"1974","journal-title":"Reprod Fertil"},{"key":"e_1_2_1_11_2","first-page":"137","article-title":"Pregnancy outcome in human couples with recurrent spontaneous abortion: HLA antigen profiles; HLA antigen sharing; female serum MLR blocking factors; and paternal leukocyte immunization","volume":"2","author":"Beer AE","year":"1985","journal-title":"Exp Clin Immunogenet"},{"key":"e_1_2_1_12_2","first-page":"223","article-title":"Sharing of human leukocyte antigens (HLA) in primary and secondary recurrent spontaneous abortions","volume":"159","author":"Ho HN","year":"1988","journal-title":"Am J Obstet Gynecol"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(81)90413-X"},{"issue":"1","key":"e_1_2_1_14_2","first-page":"896","article-title":"Effects of transfusion in women with recurrent spontaneous abortion","volume":"15","author":"Mowbray JF","year":"1983","journal-title":"Transplant Proc"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0897.1990.tb01048.x"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.80.3.830"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0897.1988.tb00171.x"},{"key":"e_1_2_1_18_2","article-title":"Paternal leucocyte injections in recurrent spontaneous abortion","volume":"1460","author":"Reznikoff MF","year":"1987","journal-title":"Lancet"},{"key":"e_1_2_1_19_2","unstructured":"ToderV. StrassburgerD. CarpH. IrlinY. LurieS. PechtM. TraininM.:Immunopotentiation and pregnancy loss. J Reprod FertilSuppl1989;79\u201384."},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0897.1993.tb00599.x"},{"key":"e_1_2_1_21_2","doi-asserted-by":"crossref","unstructured":"McConnachiePR McIntyreJA:Maternal antipaternal immunity in couples predisposed to repeated pregnancy losses. Am J Reprod Immunol1984;145\u2013150.","DOI":"10.1111\/j.1600-0897.1984.tb00186.x"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0039.1977.tb01083.x"},{"key":"e_1_2_1_23_2","doi-asserted-by":"crossref","unstructured":"PowerDA MasonRJ StewartGM CattoGRD MacLeodAM StewartKN ShewanWG:The fetus as an allograft: Evidence for protective antibodies to HLA\u2010linked paternal antigens. Lancet1983;701\u2013704.","DOI":"10.1016\/S0140-6736(83)92246-8"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198408000-00004"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0378(91)90029-P"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0378(85)90024-5"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0897.1995.tb00887.x"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0897.1994.tb01095.x"},{"key":"e_1_2_1_29_2","first-page":"53","article-title":"Analysis of anti\u2010lymphocyte antibodies by flow cytometry of microlymphocytotoxicity in women with recurrent spontaneous abortion immunized with paternal lymphocytes","volume":"30","author":"Gilman\u2010Sachs A.","year":"1989","journal-title":"J Clin Lab Immunol"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1992.32893032098.x"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(92)91785-9"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(11)91690-1"}],"container-title":["American Journal of Reproductive Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0897.1998.tb00343.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0897.1998.tb00343.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T03:34:34Z","timestamp":1698464074000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0897.1998.tb00343.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,2]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1998,2]]}},"alternative-id":["10.1111\/j.1600-0897.1998.tb00343.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0897.1998.tb00343.x","archive":["Portico"],"relation":{},"ISSN":["1046-7408","1600-0897"],"issn-type":[{"value":"1046-7408","type":"print"},{"value":"1600-0897","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,2]]}}}